FINWIRES · TerminalLIVE
FINWIRES

LongBio Pharma Raises HK$1.3 Billion in Hong Kong IPO Ahead of Debut

By

LongBio Pharma (HKG:1779) raised HK$1.25 billion in net proceeds from its initial public offering in Hong Kong.

The final offer price was set at HK$96.06 per H-share, according to a Thursday after-market filing with the Hong Kong Stock Exchange.

The Chinese biopharmaceutical company offered 14.2 million H-shares in the global offering.

The Hong Kong public offer was 4,762.58 times subscribed, with a final allocation of 1.4 million shares, representing 10% of the total offering.

The international offering was 10.94 times subscribed, with a final allocation of 12.8 million shares, or 90% of the total offering.

An over-allocation of 2.1 million shares was made under the global offering.

Cornerstone investors, including OrbiMed Genesis, The Biotech Growth Trust, TruMed Innovation Fund, TruMed Master Fund, Shanghai Gaoyi, Wisdomshire Asset Management, Vision Fund 1, and GSC Fund 1, were allotted a combined 7.1 million shares, representing 49.96% of the global offering, according to the filing.

LongBio Pharma is set to debut on the Hong Kong bourse on Friday, June 5.

Related Articles

Asia

Yest Wins KRW22.8 Billion Semiconductor Manufacturing Equipment Order from Samsung Electronics; Shares Rise 6%

Yest (KOSDAQ:122640) secured an order for optical communication network equipment from Samsung Electronics (KRX:005930), according to a Thursday filing with the Korea Exchange.The contract, valued at 22.82 billion won, is valid till Dec. 30, 2027.Shares of Yest rose nearly 6% in recent trade.

KOSDAQ:122640KRX:005930
Asia

LiComm Wins Optical Communication Network Equipment Order from 1Finity; LiComm Shares Jump 30%

Electronics manufacturer LiComm (KOSDAQ:388790) secured an order for optical communication network equipment from Fujitsu (TYO:6702) subsidiary and telecommunications and network solutions firm 1Finity, according to a Thursday filing with the Korea Exchange.The contract, valued at 3.87 billion won, is valid till Dec. 6, 2027.Shares of LiComm jumped nearly 30% in recent trade, while those of Fujitsu fell nearly 3%.

KOSDAQ:388790TYO:6702
Asia

Guoco Group to Develop Singapore Property via JV

Guoco Group (HKG:0053) agreed to set up a joint venture with real estate firms, Intrepid and TIDR, to develop a residential project in Singapore's Lentor Central, according to a Wednesday filing with the Hong Kong bourse.The project, which involves a property acquired for HK$4.03 billion via tender, spans 15,925.8 square meters and could potentially yield 562 residential units,Guoco will acquire a 50% interest in the joint venture, Intrepid will own 40%, while TIDR will take the remaining 10%.The partners will contribute HK$1.45 billion to the venture in proportion to their ownership of the JV. In Guoco's case, the capital contribution will amount to HK$724.4 million, comprising HK$165.4 million in share capital and HK$559 million in loans.A further HK$3.89 billion was arranged to finance part of the property's acquisition cost and the project's future construction costs and working capital.Guoco also agreed to provide project management and services to the project under a separate agreement that would expire on June 2, 2029.Intrepid and TIDR are associated with Guoco through its substantial shareholder Hong Leong Investment Holdings.

HKG:0053